Skip to content

Impact of Elimination or Reduction of Dietary Animal Proteins on Cancer Progression and Survival - A Pilot Study

Impact of Elimination or Reduction of Dietary Animal Proteins on Cancer Progression and Survival - A Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02437474
Enrollment
326
Registered
2015-05-07
Start date
2015-04-30
Completion date
2016-12-31
Last updated
2017-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms

Keywords

vegan diet, lacto-ovo-vegetarian diet, cancer, tumor remission

Brief summary

The purposes of this study are * to test the hypothesis that elimination or reduction of dietary animal proteins leads to an improved prognosis in tumor patients * to estimate the effect size and thus to enable sample size calculations for further studies * to test the feasibility and tolerance of different diets, especially a vegan diet, in cancer patients and to proof that a vegan diet does not lead to a deterioration of health, tumor progression or to malnutrition * to test the online platform as a study platform * to test validity of self reported and online generated data

Detailed description

Participating cancer patients select one of 3 defined diets (omnivor/lacto-ovo-vegetarian/vegan) at baseline and will continue their prescribed oncological therapy at their attending physician/clinic. Participants provide data (cancer history, tumor behavior, food frequency questionnaires, questionnaires referring to quality-of-life) at baseline and at 3 and 6 months with optional data entry points at 12 and 124 months and a follow up questionnaire at 12 and 24 months. Data is entered online via the study platforms www.essenundkrebs.net and www.foodandcancer.net in German and English language (no additional clinical visits are required).

Interventions

BEHAVIORALOmnivorous diet

Adopting or continuing the selected diet for 6 months (omnivorous)

BEHAVIORALLacto-ovo-vegetarian diet

Adopting or continuing the selected diet for 6 months (lacto-ovo-vegetarian)

BEHAVIORALVegan diet

Adopting or continuing the selected diet for 6 months (vegan)

Sponsors

University Hospital Regensburg
CollaboratorOTHER
Rosa Aspalter
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of cancer * Inclusion in a tumor treatment or follow-up program * Age \>18 years

Exclusion criteria

* Psychiatric treatment during the last 3 months * Pregnancy * Breast feeding * BMI \< 18,5 kg/m2 * Major difficulties with food intake (swallowing, lack of appetite) limiting food intake * Participation in other studies requiring the attendance to a particular diet

Design outcomes

Primary

MeasureTime frameDescription
Number / percentage of remissions6 monthsPercentages of remissions as defined be complete absence of a tumor - in an ITT (intention to treat) analysis

Secondary

MeasureTime frameDescription
Relapse-free interval0, 3, 6, 12 and 24 monthsA relapse is defined by a recurrence of a tumor after a tumor free interval.
Therapies, therapy tolerability and side-effects (vomiting, nausea, hair loss, weakness, diarrhea, polyneuropathy,...)0, 3 and 6 months (optional: 12 and 24 months)The study questionnaire contains questions referring frequently occuring symptoms in cancer patients and wether they are related to a certain therapy or to other factors. The option others is included in case the present symptoms are not covered by the listed symptoms.
Comorbidities0, 3 and 6 months (optional: 12 and 24 months)The study questionnaire contains questions referring frequently occuring diseases other than cancer and wether they are present now or were present in the past. The option others is included in case the present disease is not covered by the listed diseases.
Medication0, 3 and 6 months (optional: 12 and 24 months)The study questionnaire contains questions referring medications and supplements and the dosage.
Quality of life0, 3 and 6 months (optional: 12 and 24 months)The study questionnaire contains questions referring quality of live covering the Karnofsky Index, but additional dimensions, too (psychosocial wellbeing).
Acceptance and feasibility of the selected diet3 and 6 months (optional: 12 and 24 months)The study questionnaire contains questions referring ease and difficulties with the selected diet.
Tumor diagnosis and tumor behaviour (complete remission / partial remission / no change / progression)3 and 6 months (optional: 12 and 24 months)In the fist questionnaire, tumor history (diagnosis, classification, stage, previous therapy) is entered. At months 0, 3, 6, 12 and 24 tumor stage at present time is asked again. Comparing the staging between time points, tumor behaviour is categorized into four groups: complete remission / partial remission / no change / tumor progression. This will be determined for each participant by two investigator independently.
Frequency, extent and duration of nutritional changes3 and 6 months (optional: 12 and 24 months)The results referring to nutrition and dietary patterns are evaluated in terms of change and duration of change in dietary patterns (in months).
Weight and nutritional status0, 3, 6, 12 and 24 monthsWeight is entered in kg and size in cm. BMI is calculated. Nutritional status is derived from weight changes, laboratory test results (albumin) and questions referring to eating problems contained in the study questionnaire.
Experience with / performance of study platform0, 3 and 6 monthsOne question of the questionnaire asks for experience and usability of the comprehensive questionnaire in terms of content, understanding, effort und technical experience.
Validity checks for self reported data0, 3 and 6 monthsSeveral questions are repeated in the questionnaire in a slightly different way to check for consistency. Dietary patterns are checked via food frequency questionnaires and control questions in the laboratory test section.
Survival rates for end stages6 months, 12 and 24 monthsSurvival rates are calculated from the participants still alive and dead. In case of a pending questionnaire a contact person is asked or a cancer registry checked (depending on the citizenship of the participant).
Dietary pattern0, 3, 6, 12 and 24 monthsThe study questionnaire contains questions referring previous dietary patterns and the dietary pattern which will be followed for the time of study participation (6 months) as well as the reason for choosing the respective diet. There is a categorical question asking for dietary patterns as well a comprehensive food frequency questionnaire especially adopted for discrimination of plant an animal derived foods. In addition to the main study questionnaires, participants are asked to report any unplanned change in their diet during study participation.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026